Molina Arturo MD 的 Form 4 申報
Protagonist Therapeutics, IncPTGX,2024/11/27 申報
- 申報編號
- 0001104659-24-123809
- 申報時間
- 2024/11/27
- 交易日
- 2024/11/26-11/27
- 申報延遲
- 1 天
- 10b5-1 計畫
- 沒有勾選
這份申報列了 6 筆非衍生性交易、3 筆衍生性交易。公開市場賣出合計 $141.4 萬。交易後 1 天申報。
申報人
一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Molina Arturo MDCIK 0001398940 | 高階主管(醫療長) |
非衍生性證券(表 I)
普通股等股票的取得與處分,每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2024/11/26 | Common Stock | M行使選擇權取得 | +5,529 | $8.04 | +$44,453.16 | 51,973 | 直接 | |
| 2024/11/26 | Common Stock | S賣出處分 | −5,529 | $45.60F1 | −$252,122.4 | 46,444 | 直接 | |
| 2024/11/27 | Common Stock | M行使選擇權取得 | +10,000 | $8.04 | +$80,400 | 56,444 | 直接 | |
| 2024/11/27 | Common Stock | S賣出處分 | −10,000 | $44.50F2 | −$445,000 | 46,444 | 直接 | |
| 2024/11/27 | Common Stock | M行使選擇權取得 | +16,000 | $8.04 | +$128,640 | 62,444 | 直接 | |
| 2024/11/27 | Common Stock | S賣出處分 | −16,000 | $44.83F3 | −$717,280 | 46,444 | 直接 |
衍生性證券(表 II)
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數;單價與金額是衍生證券本身的價格,交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2024/11/26 | Common Stock | M行使選擇權處分 | −5,529 | $0.00 | $0 | 121,971 | 直接 | |
| 2024/11/27 | Common Stock | M行使選擇權處分 | −10,000 | $0.00 | $0 | 111,971 | 直接 | |
| 2024/11/27 | Common Stock | M行使選擇權處分 | −16,000 | $0.00 | $0 | 95,971 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。
- F1
The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.94. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F2
The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $43.80 to $44.92. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $44.50 to $44.99. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。